Nxera Pharma Co., Ltd.

¥1,587As of Sun 8 Nov 2026, 12:00 UTC
TSE:4565Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR (8.69%)
Div yield —
ROE (8.31%)
Biotechnology
Beta (5Y) 0.31
PE TTM —
TSR TTM 77.12%
Mkt cap ¥145.0B
ROIC 0.61%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥1,730
9.04%
(66.30%)
Hold 7|8|8|1|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
24.66
25.54
26.15
25.99
15.49%
8.43%
14.80%
14.33%
Revenue¥B
9.956
10.37
10.13
9.895
12.22%
15.43%
7.78%
0.68%
Peers (US$920.9M)
Cap (US$)
PE
866.6M
—
848.1M
—
Capital
TTM
5Y
10Y
Leveragex
0.577
0.923
0.761
EBIT/Intx
1.686
0.211
0.181
Own earn%
21.62
(146.90)
(124.04)
Sh yield%
45.85
44.25
43.57
Owners
Insiders/Inst%
2.95
41.74
Short interest%
2.72
SBC / revenue%
5.37
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
23–28
$1 testx
0.0
Incr. ROIC%
5